This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Martin Edelmann, Dipl.-Ing.
Senior Scientist, Therapeutic Modalities at F. Hoffmann-La Roche AG

Profile

I studied engineering at the University of Applied Science Mannheim in 2003 and completed my diploma thesis at Novartis in Switzerland in 2006. After 4 years of research in medicinal chemistry at the Novartis Institutes for BioMedical Research, I moved to Roche's isotope synthesis laboratory at the end of 2010. I am responsible for labelling small molecules, oligonucleotides, and proteins with carbon-14 and tritium. At the beginning of 2020 I started my PhD at the University of Bath in the department of Pharmacy & Pharmacology under supervision of Prof. Ian S. Blagbrough and Prof. Stephen M. Husbands (University of Bath) as well as Dr. Michael B. Otteneder and Dr. Filippo Sladojevich (F. Hoffmann-La Roche). The aim of my PhD thesis is to investigate new ways of radiolabelling nucleic acid based medicines and biomolecules for tracking and monitoring. My talk describes a part of my PhD on a novel method to label oligonucleotides.

Agenda Sessions

  • A Novel Access to Tritium Labelled Oligonucleotides

    14:30